{
  "id": "everyday#risk_safety_e35fad26",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "light sedatives. » Buprenorphine: Buprenorphine is given sublingually at a dose range of 4-16 mg per day » Morphine sulphate: 10-20 mg as an initial dose with 10 mg extra dose if needed. for 3-14 days for withdrawal management. Before initiating buprenorphine treatment, it is Sedation and respiratory depression which canbe life threatening. Prolonged use can lead important to wait until signs and symptoms of opioid withdrawal become evident - at least to dependence. For more details go to Table 1. 8 hours after the last dose of heroin and 24-48 hours after the last dose of methadone; otherwise, there is a risk that buprenorphine itself will precipitate a withdrawal syndrome. Special care should be taken for individuals taking other sedating medications. DISORDERS DUE TO SUBSTANCE USE 121 122 SUB 2 DISORDERS DUE TO SUBSTANCE USE Management PROTOCOL PROTOCOL 5 6 Opioid Agonist Maintenance Treatment Benzodiazepine Withdrawal » » Opioid agonist maintenance treatment requires the presence of an Benzodiazepine withdrawal can be managed by switching to a long- established and regulated national framework. It is characterized by the acting benzodiazepine and gradually decreasing the dose, tapered over prescription of long-acting opioid agonists (or partial agonists), such as 8-12 weeks, and in conjunction with psychosocial support. More rapid methadone or buprenorphine, generally on a daily, supervised basis. tapering is possible only if the person is in an inpatient setting in a There is strong evidence that agonist maintenance treatment with hospital or detoxification facility. methadone or buprenorphine effectively reduces illicit drug use, the » If severe, uncontrolled benzodiazepine withdrawal develops or occurs spread of HIV, mortality, and criminality, as well as improving physical due to a sudden or unplanned cessation, consult a specialist or other health, mental health, and social functioning. available resource person immediately to start a high-dose benzodiazepine » Monitoring: Medications used for opioid agonist maintenance treatment sedation regime and to hospitalise the person. Be cautious with are open to misuse and diversion, hence, programmes should use various unsupervised dispensing of benzodiazepines to unknown patients. methods of limiting the risk of diversion, including supervised consumption. » For more details please see Table 1.",
  "gloss_vi": "Light sedatives. » buprenorphine: buprenorphine is given sublingually at a dose range of 4-16 mg per day » morphine sulphate: 10-20 mg as an initial dose with 10 mg extra dose if needed.",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "screening_cues",
      "referral",
      "psychoeducation"
    ],
    "life_topics": [
      "work"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn light sedatives. » Buprenorphine: Buprenorphine is given sublingually at a dose range of 4-16 mg per day » Morphine sulphate: 10-20 mg as an initial dose with 10 mg extra dose if needed. for 3-14 days for withdrawal management. Before initiating buprenorphine treatment, it is Sedation and respiratory depression which canbe life threatening. Prolonged use can lead important to wait until signs and symptoms of opioid withdrawal become evident - at least to dependence. For more details go to Table 1. 8 hours after the last dose of heroin and 24-48 hours after the last dose of methadone; otherwise, there is a risk that buprenorphine itself will precipitate a withdrawal syndrome. Special care should be taken for individuals taking other sedating medications. DISORDERS DUE TO SUBSTANCE USE 121 122 SUB 2 DISORDERS DUE TO SUBSTANCE USE Management PROTOCOL PROTOCOL 5 6 Opioid Agonist Maintenance Treatment Benzodiazepine Withdrawal » » Opioid agonist maintenance treatment requires the presence of an Benzodiazepine withdrawal can be managed by switching to a long- established and regulated national framework. It is characterized by the acting benzodiazepine and gradually decreasing the dose, tapered over prescription of long-acting opioid agonists (or partial agonists), such as 8-12 weeks, and in conjunction with psychosocial support. More rapid methadone or buprenorphine, generally on a daily, supervised basis. tapering is possible only if the person is in an inpatient setting in a There is strong evidence that agonist maintenance treatment with hospital or detoxification facility. methadone or buprenorphine effectively reduces illicit drug use, the » If severe, uncontrolled benzodiazepine withdrawal develops or occurs spread of HIV, mortality, and criminality, as well as improving physical due to a sudden or unplanned cessation, consult a specialist or other health, mental health, and social functioning. available resource person immediately to start a high-dose benzodiazepine » Monitoring: Medications used for opioid agonist maintenance treatment sedation regime and to hospitalise the person. Be cautious with are open to misuse and diversion, hence, programmes should use various unsupervised dispensing of benzodiazepines to unknown patients. methods of limiting the risk of diversion, including supervised consumption. » For more details please see Table 1. Light sedatives. » buprenorphine: buprenorphine is given sublingually at a dose range of 4-16 mg per day » morphine sulphate: 10-20 mg as an initial dose with 10 mg extra dose if needed."
}